Minkyu Park

Minkyu represents companies and investment banks on various complex capital markets transactions across life sciences, technology, financial services and consumer sectors – spanning initial public offerings, follow-on offerings, private investment in public equity (PIPE) financings, debt offerings and liability management transactions. He regularly advises on cross-border transactions in Europe and Asia, including Abivax’s IPO and follow-on offering – the largest equity financings by a French biotech company. Minkyu also counsels U.S. and international public companies, including their board of directors and committees, in connection with Securities and Exchange Commission (SEC) reporting and corporate governance matters.

Before law school, Minkyu served in the Korean military battalion of the United Nations Interim Force in Lebanon to conduct peacekeeping operations. He brings the discipline, teamwork and cross-cultural perspective gained from his military experience to advising clients on sophisticated business matters.

Representative equity transactions:

• Evommune in its $173 million IPO and $125 million PIPE
• LB Pharmaceuticals in its $328 million IPO and $100 million PIPE
• Abivax in its $236 million IPO and $748 million equity follow-on offering
• Keros Therapeutics in its $161 million equity follow-on offering
• Tectonic Therapeutics in its $185 million PIPE
• VYNE Therapeutics in its $88 million PIPE
• Underwriters in Caris Life Science’s $568 million IPO
• Underwriters in Oruka Therapeutics’ $700 million equity follow-on offering
• Underwriters in Altimmune’s $225 million equity follow-on offering
• Underwriters in NewAmsterdam Pharma’s various equity follow-on offerings
• Underwriters in Rent the Runway’s $357 million IPO
• Underwriters in Cerevel Therapeutics’ $254 million equity follow-on offering and concurrent $345 million convertible notes offering
• Underwriters in Verona Pharma’s $150 million equity follow-on offering

Representative debt transactions:

• Jazz Pharmaceuticals in its $1.0 billion convertible notes offering
• Underwriters in $1.5 billion investment-grade notes offering by a consumer goods company
• Underwriters in Jefferies Financial Group’s $1.5 billion and $1.0 billion investment-grade notes offerings
• Underwriters in Vizsla Silver’s $300 million convertible notes offering
• Underwriters in Ur-Energy’s $120 million convertible notes offering
• Underwriters in Semler Scientific’s $100 million convertible notes offering
• Underwriters in McEwen Minings’ $110 million convertible notes offering